Frontline Forum | Expert Perspectives in the Management of Basal Cell Carcinoma (BCC)

Experts in dermatology comment on the patient considerations required when deciding on systemic treatment for basal cell carcinoma.

Drs Sarah Arron and Nathalie Zeitouni share their insights into how they define locally advanced basal cell carcinoma and when they introduce multidisciplinary care.

In the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.

In part 3 of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, discuss non-surgical treatment options for the management of BCC, dose adjustments for systemic treatments, combining hedgehog pathway inhibitors with immunotherapy, and more.